Answers are grounded in this paper and cite their sources.
Maturity onset diabetes of the young (MODY) accounts for 1-2% of all diabetes.(1) An 11-year-old female girl was diagnosed with diabetes with typical diabetes symptoms, and laboratory findings of diabetic ketoacidosis and multiple-dose insulin therapy were started. In the follow-up, she had diabetes autoantibody negativity and a MODY panel was applied. It was reported that a novel heterozygous variant [(NM_000207.3: c.76G>A (p.Val26Met) (Exon2)] in the insulin (2) gene, causing MODY 10, one of the rare types of MODY. Her parents were negative for the variant, so the variant was de-nova. MODY 10 can cause diabetic ketoacidosis, and patients can be misdiagnosed with type 1 diabetes. Screening for variations in identified MODY genes should be kept in mind in patients who require small insulin doses and have negativity for diabetes autoantibodies.
No takes yet. Share an insight, caveat, or question.
Onguner et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: